The aortic aneurysm market in Canada is expected to reach a projected revenue of US$ 425.5 million by 2033. A compound annual growth rate of 11.9% is expected of Canada aortic aneurysm market from 2026 to 2033.
W.L. Gore & Associates, Medtronic PLC, MicroPort Scientific Corp, Cook Group, Cryolife, Cardinal Health Inc, Terumo Corp, Endologix, Lombard Medical
Other key industry trends
In terms of revenue, Canada accounted for 3.5% of the global aortic aneurysm market in 2025.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
In North America, U.S. aortic aneurysm market is projected to lead the regional market in terms of revenue in 2033.
U.S. is the fastest growing regional market in North America and is projected to reach USD 5,439.4 million by 2033.
The Canadian thoracic aortic aneurysm market is expected to witness lucrative growth over the forecast period. This can be attributed to growing preference for minimally invasive surgical procedures, technological advancements, and increase in geriatric population suffering from endovascular aneurysm diseases.
Leading players in the thoracic aortic aneurysm market are actively manufacturing and commercializing their products in the Canadian market as the demand for efficient products is high. Cook Medical is an established player in the market with its device Zenith TX2 thoracic endograft platform, which received FDA approval in 2008.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Aortic Aneurysm Market Outlook will help companies and investors design strategic landscapes.
Abdominal Aortic Aneurysm (Aaa) was the largest segment with a revenue share of 70.75% in 2025.
Horizon Databook has segmented the Canada aortic aneurysm market based on thoracic aortic aneurysm (taa), abdominal aortic aneurysm (aaa) covering the revenue growth of each sub-segment from 2021 to 2033.
The Canadian thoracic aortic aneurysm market is expected to witness lucrative growth over the forecast period. This can be attributed to growing preference for minimally invasive surgical procedures, technological advancements, and increase in geriatric population suffering from endovascular aneurysm diseases.
Leading players in the thoracic aortic aneurysm market are actively manufacturing and commercializing their products in the Canadian market as the demand for efficient products is high. Cook Medical is an established player in the market with its device Zenith TX2 thoracic endograft platform, which received FDA approval in 2008.
Canada Aortic Aneurysm Market Type Outlook (Revenue, USD Million , 2021-2033)
Thoracic Aortic Aneurysm (TAA)
Abdominal Aortic Aneurysm (AAA)
Canada Aortic Aneurysm Market Treatment Outlook (Revenue, USD Million , 2021-2033)
Open Surgical Repair (OSR)
Hybrid procedures
Endovascular Aneurysm Repair (EVAR)
Thoracic Endovascular Aneurysm Repair (TEVAR)
Fenestrated Endovascular Aneurysm Repair (FEVAR)
Branched Endovascular Aneurysm Repair (BEVAR)
Canada Aortic Aneurysm Market Product Outlook (Revenue, USD Million , 2021-2033)
Aortic Stent Grafts
Aortic Surgical Grafts
Aortic Repair Accessory Devices
Canada Aortic Aneurysm Market End Use Outlook (Revenue, USD Million , 2021-2033)
Hospitals
Ambulatory Surgery Centers (ASC)
Clinics
Reasons to subscribe to Aortic Aneurysm Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Aortic Aneurysm Market Outlook databook
Our clientele includes a mix of Aortic Aneurysm Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada Aortic Aneurysm Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Canada Aortic Aneurysm Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.